NASDAQ: GEVOGevo Inc Stock
$1.40-0.07 (-4.76%)
Updated Jun 12, 2026
GEVO Price
$1.40
Fair Value Price
N/A
Market Cap
$340.78M
52 Week Low
$1.12
52 Week High
$2.97
P/E
-10.77x
P/B
0.76x
P/S
3.71x
PEG
N/A
Dividend Yield
N/A
Revenue
$174.42M
Earnings
-$33.81M
Gross Margin
51.8%
Operating Margin
-8.24%
Profit Margin
-19.4%
Debt to Equity
0.44
Operating Cash Flow
-$10M
Beta
1.85
Next Earnings
Aug 10, 2026
Ex-Dividend
N/A
Next Dividend
N/A
GEVO Overview
Gevo, Inc. is a company focused on the development and commercialization of renewable fuels. Its operations are organized into four distinct segments: Gevo, Agri-Energy, Renewable Natural Gas, and Net-Zero. The company's primary objective is to offer sustainable alternatives for gasoline, jet fuel, and diesel, striving to achieve zero carbon emissions and substantially lower overall greenhouse gas footprints. Their diverse product offerings include renewable versions of gasoline and diesel, sustainable aviation fuel (SAF), and renewable natural gas. Additionally, they produce specialty chemicals like isooctane, isobutanol, isobutylene, and ethanol, along with animal feed and protein. Gevo, Inc. has formed a strategic partnership with Axens North America, Inc. to advance ethanol-to-jet technology and further the commercial development of sustainable aviation fuel projects. Originally founded in 2005 as Methanotech, Inc., the company changed its name to Gevo, Inc. in March 2006. Its corporate headquarters are located in Englewood, Colorado.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine GEVO's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
A
GEVO
Ranked#51 of 51
Ranked#51 of 51
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $5.70 | A | |
| $43.41 | A | |
| $13.09 | A |
Be the first to know about important GEVO news, forecast changes, insider trades & much more!
GEVO News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how GEVO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GEVO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
GEVO is good value based on its book value relative to its share price (0.76x), compared to the US Specialty Chemicals industry average (3.78x)
P/B vs Industry Valuation
GEVO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more GEVO due diligence checks available for Premium users.
Valuation
GEVO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-10.77x
Industry
7.39x
Market
14.15x
GEVO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.76x
Industry
3.78x
GEVO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
GEVO's financial health
Profit margin
Revenue
$42.9M
Net Income
-$21.7M
Profit Margin
-50.5%
GEVO's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
GEVO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$653.5M
Liabilities
$198.8M
Debt to equity
0.44
GEVO's short-term assets ($115.87M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GEVO's long-term liabilities ($171.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GEVO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
GEVO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$21.1M
Investing
-$9.1M
Financing
-$7.8M
GEVO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
GEVO vs Specialty Chemical Stocks
Gevo Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.